GAPDH with NAD+-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'GAPDH with NAD<sup>+</sup>-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds